Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

2(28.6%)

7Total

N/A(5)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03459157Not ApplicableCompleted

Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

Role: collaborator

NCT02626286Not ApplicableCompleted

Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa

Role: collaborator

NCT05133661Active Not Recruiting

SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)

Role: collaborator

NCT05655702Not ApplicableRecruiting

DRug Use & Infections in ViEtnam: TuBerculosis Control

Role: collaborator

NCT05535465Not ApplicableUnknown

Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities

Role: collaborator

NCT05368675Phase 4Completed

Medication-assisted Treatment for Injecting Drug Users in Vietnam

Role: collaborator

NCT02752152Not ApplicableCompleted

Counseling and Reminders for Regular HIV and STIs Screening

Role: collaborator

NCT03723525Phase 4Completed

Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected Individuals

Role: collaborator

All 8 trials loaded